Platforms & Technologies

 

PLATFORM / TECHNOLOGY DESCRIPTIONPRECLINICAL PIPELINECLINICAL PIPELINEMARKED PRODUCTS

Hyperimmunes

anthrasil

 

Human – Purified gamma globulin (IgG) containing

 

 

VIGIV

 

polyclonal antibodies to specific antigen(s) obtained

 

 

 

 

from fractionation of human plasma

 

 

 

 

 

 

 

 

 

Equine – Purified immune globulin fragments derived

BAT®

 

from polyclonal antibodies to specific antigen(s) obtained

 

 

 

 

from fractionation of equine plasma

 

 

 

 

 

 

 

Emergard™ (auto-injector)

 

Military-grade auto-injector device

 

 

 

 

 

 

 

Antivirals

Dengue

 

Broad-spectrum antiviral iminosugars with a mechanism

 

 

 

 

of action that inhibits a host glycosylation pathway resulting

 

 

 

 

in misfolded viral glycoproteins subsequently leading to

 

 

 

 

reduced viral infectivity

 

 

 

 

 

 

 

Antibacterials

 

EV-035 series of molecules with a novel 4-oxoquinolizine

 

 

 

 

antibacterial backbone showing activity against

 

 

 

 

quinolone-resistant bacterial strains

 

 

 

 

 

 

 

MVAtor™ (modified vaccinia virus Ankara vector)

Respiratory Syncytial

 

Recombinant, live, attenuated viral vector for the

Virus (RSV)

 

 

 

development of vaccines

Universal flu

 

 

 

 

Ebola